Menu
PacPremier
Magic Hour
Montecito
SoCal Gas
Loading...
You are here:  Home  >  'Kirin-Amgen'
Latest

Amgen buying out joint venture Kirin-Amgen for $780 million

By   /  Tuesday, October 31st, 2017  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Amgen buying out joint venture Kirin-Amgen for $780 million

Amgen, the biotech giant based in Thousand Oaks, announced that it would buy out joint venture Kirin-Amgen, which was created to develop white blood cell booster Neupogen among other projects, for $780 million. The joint venture holds intellectual property rights for Neupogen, Neulasta, Aranesp, Nplate and brodalumab. In addition to the cash deal, Amgen will Read More →

Read More →